Answers are grounded in this paper and cite their sources.
Investigates fetal microchimerism's influence on risk in women with PAH, suggesting a link to sex chromosomes and pregnancy.
Rationale While pulmonary arterial hypertension (PAH) is a sexually dimorphic disease, the contribution of sex chromosomes to human PAH is unknown. Microchimerism, the bidirectional exchange of fetal and maternal cells across the placenta, has not been studied in PAH. Methods In peripheral blood mononuclear cells (PBMCs) from female PAH subjects who had a prior pregnancy, genomic testing was performed. Persistent fetal microchimerism was defined as HLA mismatching or the presence of the Y-chromosome (Infinium global screening array (GSA)-24 v3.0 BeadChip by Illumina; CD Genomics, NY) in female samples. Never pregnant PAH, male PAH, non-PAH participants, and chimeric controls (solid organ transplant recipients) were also included. Results HLA-genotyping and GSA has been completed for 39 participants. Twenty-two (56%) carry a diagnosis of PAH, 19 of whom are female (86.3%) with a median age of 66 years (range 39). Two (5%) female PAH patients have had remote non-thoracic solid organ transplants and serve as chimeric controls (median age 57 years, range 28). Of the remaining 17 samples, 15 (88%) are female non-PAH participants (Table 1). HLA-genotyping did not detect evidence of microchimerism including in two transplant “positive controls.” Among all samples (n = 39), HLA-testing identified diploid and/or allelic ambiguity in 38% (15/39). Among PAH samples excluding the transplant recipients (n = 20), six (30%) had evidence of diploid or allelic ambiguity. Five of these six (83%) were female, four (80%) of whom have had male offspring. One male idiopathic PAH patient had positive ambiguity. Diploid ambiguity was identified in a congenital heart disease (CHD) associated-PAH patient who had a childhood liver transplant. GSA was completed and analysis of the 4000+ markers of the Y-chromosome is underway. Using a call score > 0.4, Y-chromosome single nucleotide variants (Y-SNVs) and polymorphisms (Y-SNPs) have been detected in five (29 %) female PAH samples (4/5, 80% had male offspring), one transplant recipient (CHD-PAH liver transplant), and one non-PAH female. Whether these results represent the pseudoautosomal region of Y, contamination, or a true result is being analyzed. Conclusions We detected allelic and diploid ambiguity, Y-SNVs and Y-SNPs in female PAH participants who tended to have male offspring. While both may be signs of persistent microchimerism, further testing is needed. Once completed, this study could provide the first direct evidence that sex chromosomes and pregnancy modify risk in PAH through microchimerism.
No takes yet. Share an insight, caveat, or question.
Sherman-Roe et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: